Brief periods of oxygen deprivation to the brain have been shown to provide neuroprotective effects that reduce stroke infarct size and improve recovery times.
The trial, sponsored by the University of Birmingham, is currently recruiting participants.
Significant infarct progression can make patients ineligible for mechanical thrombectomy.
Risk scores help identify high-risk patients who may benefit from intervention.
Mechanisms including silent cerebral infarct, microemboli, microbleedings, and cerebral hypoperfusion may be responsible for the link between atrial fibrillation and cognitive decline.
The findings support the continuation of high-intensity statin therapy after acute ischemic stroke.
Insulin-resistant patients with ischemic stroke or transient ischemic attack and a high risk of myocardial infarction or recurrent stroke are more likely to derive benefit from pioglitazone than those a lower risk.
There is a reduced risk of adverse events associated with genotype-guided warfarin dosing.
For long-term low-dose aspirin users, there is a 30% increased risk of CVD events with discontinuation of aspirin.
Low-dose oxygen use does not reduce death or disability at 3 months among patients with acute stroke.
A better understanding of characteristics of cerebral lesions may help expedite treatment and improve functional outcomes.
Neurology Advisor Articles
- Migraine and Gastrointestinal Disorders: Elucidating an Association
- Brain Health in Contact Sports: Putting It All on the Line
- Alzheimer's Disease Risk Similar in Women and Men With APOE ε3/ε4 Genotype
- Non-Invasive Magnetic Device Approved by FDA for Migraine Tx
- FDA Approves Device for Tx of Chronic Pain